EGM
CTKB icon

Engineers Gate Manager’s Cytek Biosciences CTKB Stock Holding History

Engineers Gate Manager’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,607
Closed -$78.6K – 2216
2025
Q1 		$78.6K Buy
+19,607
New +$102K ﹤0.01% 2021
2023
Q1 		– Sell
-32,796
Closed -$335K – 1708
2022
Q4 		$335K Buy
+32,796
New +$441K 0.02% 1130
2022
Q2 		– Sell
-32,799
Closed -$354K – 1972
2022
Q1 		$354K Buy
+32,799
New +$443K 0.01% 1282

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Engineers Gate Manager's CTKB Position: Q2 2025 in Review

Engineers Gate Manager sold out of Cytek Biosciences (CTKB) in Q2 2025, closing a stake of 19,607 shares — an estimated $78.6K sold.

Engineers Gate Manager first reported a position in CTKB in Q1 2022 and held it in 3 quarters. The position peaked at $354K in Q1 2022. 158 funds tracked by Wall St. Rank hold CTKB as of Q2 2025.

  • Engineers Gate Manager reported no remaining Cytek Biosciences position as of Q2 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 19,607 Cytek Biosciences shares in Q2 2025, an estimated $78.6K.
  • Engineers Gate Manager first reported a position in Cytek Biosciences in Q1 2022 and held it in 3 quarters.
  • Engineers Gate Manager's Cytek Biosciences position peaked at $354K in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.